Charlene Thornton1, Jane Tooher2, Robert Ogle3, Peter von Dadelszen4, Angela Makris5, Annemarie Hennessy6. 1. Western Sydney University, School Of Medicine, Locked Bag 1797 Penrith South, NSW Australia. Electronic address: c.thornton@westernsydney.edu.au. 2. Royal Prince Alfred Women and Babies, Missenden Road, Camperdown, NSW Australia. Electronic address: j.tooher@sswahs.nsw.gov.au. 3. Royal Prince Alfred Women and Babies, Missenden Road, Camperdown, NSW Australia. Electronic address: r.ogle@sswahs.nsw.gov.au. 4. Department of Obstetrics and Gynaecology, University of British Columbia, Oak Street, Vancouver, Canada. Electronic address: pdadelszen@cw.bc.ca. 5. Liverpool Hospital Renal Medicine, Liverpool, Australia. Electronic address: amakris@sswahs.nsw.gov.au. 6. Western Sydney University, School Of Medicine, Locked Bag 1797 Penrith South, NSW Australia. Electronic address: an.hennessy@westernsydney.edu.au.
Abstract
INTRODUCTION: The Hypertensive Disorders of Pregnancy (HDP) affect 7-10% of pregnancies worldwide and are one of the leading causes of mortality and morbidity in the perinatal period. An accurate assessment of mortality and morbidity is essential to provide effective care and treatment and benchmarking of these issues is required to enhance outcomes and define standards. AIM: To benchmark outcomes for women and babies following a diagnosis of hypertension between obstetric units in similar settings. METHODS: Utilising a set of pre-defined clinical indicators, Individual Patient Data analysis techniques applied to the medical records of all women diagnosed with a HDP over a 12month period at six obstetric units within Australia and Canada. Statistical analysis included contingency table sand means testing oas appropriate utilising IBM SPSS V.18. RESULTS: Overall HDP rate of 7.6% of all deliveries, with a 3.0% preeclampsia rate. Outcomes differed significantly between units and did not cluster within any individual unit.
INTRODUCTION: The Hypertensive Disorders of Pregnancy (HDP) affect 7-10% of pregnancies worldwide and are one of the leading causes of mortality and morbidity in the perinatal period. An accurate assessment of mortality and morbidity is essential to provide effective care and treatment and benchmarking of these issues is required to enhance outcomes and define standards. AIM: To benchmark outcomes for women and babies following a diagnosis of hypertension between obstetric units in similar settings. METHODS: Utilising a set of pre-defined clinical indicators, Individual Patient Data analysis techniques applied to the medical records of all women diagnosed with a HDP over a 12month period at six obstetric units within Australia and Canada. Statistical analysis included contingency table sand means testing oas appropriate utilising IBM SPSS V.18. RESULTS: Overall HDP rate of 7.6% of all deliveries, with a 3.0% preeclampsia rate. Outcomes differed significantly between units and did not cluster within any individual unit.
Authors: Rachael Taylor; Vanessa A Shrewsbury; Lisa Vincze; Linda Campbell; Robin Callister; Felicity Park; Tracy Schumacher; Clare Collins; Melinda Hutchesson Journal: Front Cardiovasc Med Date: 2019-09-26